64 related articles for article (PubMed ID: 341420)
1. [Effect of the estrogen antagonist tamoxifen in the treatment of advanced mastocarcinoma (author's transl)].
Szepesi T; Kärcher KH
Strahlentherapie; 1977 Dec; 153(12):832-6. PubMed ID: 341420
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of the antioestrogenic agent tamoxifen in the treatment of metastatic breast cancer (author's transl)].
Szepesi T; Czech W
Wien Klin Wochenschr; 1978 Feb; 90(4):133-41. PubMed ID: 625990
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen-induced remissions in stage IV breast cancer.
Manni A; Trujillo J; Marshall JS; Pearson OH
Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of tamoxifen versus tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women.
Mouridsen HT; Ellemann K; Mattsson W; Palshof T; Daehnfeldt JL; Rose C
Cancer Treat Rep; 1979 Feb; 63(2):171-5. PubMed ID: 376131
[TBL] [Abstract][Full Text] [Related]
5. [Anti-oestrogen treatment of metastasising carcinoma of the breast (author's transl)].
Henningsen B; Amberger H
Dtsch Med Wochenschr; 1977 May; 102(19):713-6. PubMed ID: 870301
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced breast cancer with tamoxifen (author's transl)].
Alonso Muñóz A; Pérez Manga G; Moreno Esteban B; Muñóz Gómez S; Madrigal Alonso PL; Pérez Modrego S
Med Clin (Barc); 1980 Jul; 75(3):93-7. PubMed ID: 7401744
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
[TBL] [Abstract][Full Text] [Related]
9. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
Klaassen DJ; Rapp EF; Hirte WE
Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Spremulli EN; Raney M; Logan T
Cancer Treat Rep; 1986 Oct; 70(10):1199-203. PubMed ID: 3530447
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogen treatment of breast cancer: an overview.
Pearson OH; Manni A; Arafah BM
Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
[TBL] [Abstract][Full Text] [Related]
12. [Use of tamoxifen in patients with disseminated and local breast neoplasms].
Semiglazov VF; Gershanovich ML; Kondrat'ev VB; Moiseenko VM
Vopr Onkol; 1984; 30(9):39-43. PubMed ID: 6495691
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen in the palliative treatment of advanced breast cancer. A clinical review.
Orr JD; Macdonald JA; Thomson JW
J R Coll Surg Edinb; 1979 May; 24(3):141-7. PubMed ID: 88517
[No Abstract] [Full Text] [Related]
14. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
15. [Additive treatment of metastasizing breast cancer with special reference to postmenopausal age (results of a randomized study)].
Firusian N; Schietzel M
Strahlentherapie; 1976 Sep; 152(3):235-47. PubMed ID: 968923
[TBL] [Abstract][Full Text] [Related]
16. [Results of anti-estrogen therapy in metastatic breast cancer (preliminary results). Part II].
Firusian N; Schmidt CG
Med Welt; 1977 Dec; 28(51-52):2065-7. PubMed ID: 414049
[No Abstract] [Full Text] [Related]
17. Antiestrogen tamoxifen in the treatment of advanced breast cancer: a series of 31 patients.
Viladiu P; Bosch FX; Benito E; Alonso MC
Cancer Treat Rep; 1977 Aug; 61(5):899-900. PubMed ID: 329983
[No Abstract] [Full Text] [Related]
18. Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
Krook JE; Ingle JN; Green SJ; Bowman WD; Everson LK; Windschitl HE; Marschke RF; Laurie JA; Cullinan SA; Pfeifle DM
Cancer Treat Rep; 1985 Apr; 69(4):355-61. PubMed ID: 3888386
[TBL] [Abstract][Full Text] [Related]
19. Current overview of EORTC clinical trials with tamoxifen.
Heuson JC
Cancer Treat Rep; 1976 Oct; 60(10):1463-6. PubMed ID: 1021227
[TBL] [Abstract][Full Text] [Related]
20. [Hormone therapy of metastasizing breast cancer with tamoxifen].
Köhler A; Noss W; Dobberstein N; Stoltmann R; Pohl J
Z Gesamte Inn Med; 1986 Jan; 41(1):6-9. PubMed ID: 3953121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
